Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 24, 2021 | QureBio | $31.4M Series B | — | Lihehongxin Venture Capital Partnership, Oriza Holdings |
| Apr 22, 2021 | WeMed | $46.2M Series D | Bin Li Li Bin | 申红权 |
| Feb 23, 2021 | SinoTau | $49.5M Series D | — | — |
| Oct 26, 2020 | Sirnaomics | $105.0M Series D | Donald Dai, shi shenghao, Yunchun Li | Alpha Win Capital, HongTao Capital, Sangel Capital |
| Sep 17, 2020 | KYEE | $64.0M Series D | Tencent | Beijing Meihe Zhongbang Technology, Dyee Capital, Jiaxing Guangrun |
| Jan 2, 2020 | CF PharmTech | $90.0M Series E | 蔡磊 | CMB International, CR-CP Life Science Fund, Finnova Capital, GTJA Investment Group, Oriza Holdings |